Concepedia

Silvia Mangiacavalli

SM

Statistics

Publications

37

Citations

2.8K

H-Index

22

Active since

2000

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

University of Pavia

Policlinico San Matteo Fondazione

National and Kapodistrian University of Athens

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

Silvia Mangiacavalli is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

2000–2024

37

Publications

37

Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients

Marzia Varettoni, Alessandro Corso, Gian-Matteo Pica et al. · Annals of Oncology · 2009 · 477 citations

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro et al. · New England Journal of Medicine · 2023 · 435 citations · Full text

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 375 citations · Full text

, , +6

Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström’s macroglobulinemia and related lymphoid neoplasms

Marzia Varettoni, Luca Arcaini, Silvia Zibellini et al. · Blood · 2013 · 321 citations · Full text

A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma

Alessandro Corso, Marzia Varettoni, Patrizia Zappasodi et al. · Leukemia · 2007 · 114 citations

, , +6

1–5 of 37